Remove Conference Remove Pricing Remove San Diego Remove Startup
article thumbnail

What Makes a Successful Startup Community? Is it Possible to Build One Where You Live?

Both Sides of the Table

Recently I wrote a post arguing to make the definition of a Startup more inclusive than that to which Silicon Valley, fueled by Venture Capital return profiles, would sometimes like to attach to the word. Most of what I think about startup communities came from mentorship by Brad Feld through hours of private discussion and debate.

Startup 378
article thumbnail

Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More

Xconomy

Munich, Germany, hosted the annual conference of the European Society for Medical Oncology, where cancer drug developers unveiled the latest clinical data for experimental immunotherapies and drugs that treat the disease based on a tumor’s genetic signature.

Pricing 86
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More

Xconomy

The consternation about President Donald Trump’s coming pick for FDA commissioner was palpable this week at the BIO CEO & Investor Conference in New York.

Pricing 61
article thumbnail

Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More

Xconomy

—As the North American Cystic Fibrosis Conference kicked off in Orlando, FL, Vertex Pharmaceuticals (NASDAQ: VRTX ) said a key part of its plan to defend its industry-leading cystic fibrosis franchise is moving forward. THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases.

Pricing 40
article thumbnail

Request Your Invite for Our Napa Summit, June 14-15

Xconomy

In the heart of California’s wine country, it is our most exclusive, intimate, and unique conference. We have special prices for those at startups and non-profit or government organizations—so ask us about those as. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

article thumbnail

Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More

Xconomy

We’ll start this week with biotech deals, one featuring a couple of CAR-T heavyweights who have re-emerged after selling Kite Pharma for $12 billion. The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms.

Study 55
article thumbnail

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

. —Meanwhile, check out reports here , here , and here for some of the other headlines coming out of ASCO, including progress made in cancer immunotherapy, the ups and downs from various presenting companies, and a visit from Vice President Joe Biden. The new prices don’t reflect rebates and discounts.